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Sinusitis is one of the most infectious diseases that affect holes around the nose such as frontal ethmoid sinuses, 
maxillary and sphenoid. Symptoms usually include nasal congestion and obstruction, feeling of pressure or fullness 
in the face, anterior or posterior nasal causing discharge , headaches, fever, swelling and erythema in forehead or 
cheek and cough. The symptoms might be edema and mucosal congestion, nasal drainage, posterior nasal 
discharge, nasal septum deviation and polyps. The medicinal plants identified for instance are Amygdalus scoparia 
Spach, Echinophora platyloba DC., Haplophyllum perforatum L, Lavandula stoechas L, Borago officinalis, 
Matricaria recutita, Descurainia Sophia (L.) Schr and Haplophyllum perforatum L to treat sinusitis in Shiraz. Many 
of these plants have antioxidant activity and contain bioactive compounds such as flavonoids, flavonoids, 
polyphenols, anthocyanins, tannins and many other pharmaceutical bioactive ingredients that have effects on 
sinusitis. This paper aims to review the recently published papers in this topic. 
 





Nowadays, infectious and non-infectious diseases and the tolerance to drugs are expanding day by day [1-9]. 
Understanding the epidemiology and prevention and control and their treatment is of particular importance [10-28]. 
Sinusitis is one of the most common reasons patients visit the doctor [29]. Sinusitis is the fifth most common 
diseases in America which each year about 25 million people in this country will be diagnosed with the disease and 
antibiotics are prescribed [30-32]. Sinusitis is one of the most infectious diseases that affect holes around the nose 
such as frontal ethmoid sinuses, maxillary and sphenoid. Chronic sinusitis refers to the cases of patients, more than 
three months have passed from the onset of illness [33, 34]. 
 
Symptoms usually include nasal congestion and obstruction, feeling of pressure or fullness in the face, anterior or 
posterior nasal discharge. It causes headaches, fever, swelling forehead or cheek and cough and the symptoms 
include nasal mucosal edema and hyperemia, drainage, posterior nasal discharge, nasal septum deviation and polyps 
[35-37]. 
 
Different fungi are able to create cells in the sinuses in different ranges of diseases, which are a type of invasive 
fungal sinusitis to saprophytic and finally fungal allergic sinusitis (fungus Ball) is different. It may cause by fungi 
such as Aspergillus and Mucoracae which Mucoracae is most of them [38]. Chronic rhinosinusitis is not only a 
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physical disease but also affect people's daily functioning and mental health. Most patients have nasal congestion, 
thick mucus secretions, decreased sense of smell, headache, facial pain and decreased quality of life, often after 
several physicians refer appropriate treatment [39-41]. The precise reason of chronic rhinosinusitis is unknown, but 
it is often a wide range of bacterial pathogens are considered in these patients [42, 43]. A variety of aerobic bacteria, 
anaerobic organisms and fungi found growing in patients with sinusitis [46-44]. In addition to viral infections, other 
factors such as allergies, swimming, obstruction of polyps, tumors and foreign bodies, humoral or cellular immune 
disorders, anatomy and mucociliary dysfunction and cystic fibrosis predisposing factors more for bacterial sinusitis 
and in some situation for viral infections [47]. Chronic sinusitis is a disease that affects a significant percentage of 
the population and their long-term effects and discomfort to follow. The increasing use of drugs and antibiotic 
treatments and therapies in the treatment of patients with endoscopic surgery has opened new horizons and also alter 
the emergence of disease involvement [48]. Long-term use multiple medications, including antibiotics; put forward 
the hypothesis that exposure can cause changes in the medical treatment pattern of the pathogen in chronic sinusitis. 
Nowadays, chemical drugs are widely consumed. These drugs have deleterious side effects of herbal medicines on 
consumer health [49-59]. Medicinal plantس since ancient times been a source of cheap and accessible people [68-
60] and people preferred to use herbal medicines with the least side effects [73-69]. Ethnobotanical knowledge is the 
best way to know the therapeutic effects of medicinal plants [74-76]. The Ethnobotanical studies identified 
traditional healing properties of plants by people of culture and specific logic [77-83]. This knowledge makes certain 
species in certain areas where drugs are used as a source of modern science still has not lost to them [84-89]. In this 
study, we tried to identification and reporting medicinal plants native to the Shiraz city, which are used to control 
and treat sinusitis. 
 
MATERIALS AND METHODS 
 
Area of study 
Shiraz, Fars province is one of the major cities Irano center. Solar population of over 1,460,665 tonnes of Shiraz in 
1390 that figures, taking into account the population living in the suburbs to 1,700,687 tons. Shiraz in the Fars 
province, at an altitude of 1486 meters above sea level and is located in the Zagros mountain region and has a 
moderate climate. The city from the West to the Drake Mountains, from the north to the Bemou, Sabzpoushan, 
Chehelmagham and Babakouhi Mountains (of the Zagros mountain range) is limited. Shiraz, Fars province with a 
length of 40 km and width varies between 15 to 30 km with an area of 1268 square km southwest of Iran rectangular 
shape and geographically located in the central part of the Gulf. The average temperature in July (the hottest month) 
to 30 degrees Celsius, in January (the coldest month), 5 degrees Celsius, on April 17 ° C and in September 20 ° C 
recorded and average annual temperature is 18 degrees Celsius and annual rainfall in Shiraz is 3378 mm. 
 
The methodology used to collect the efficacy of medicinal plants 
Traditional health information collected for the period July to September of 2015 through interviews and 
questionnaires in the Shiraz city. The prepared questionnaire offered for herbalists. The questionnaires included 
information about the location, the identity of the interviewer, the name of the native plants, native consumption, the 
use, the use, the growing season and the plants were kept at home. The researchers personally referred to grocery 
stores and get information and registered their beliefs treatment plant. The results of the questionnaires were 




The results of the questionnaires revealed a total of 8 medicinal plants from 6 families for the treatment of sinusitis 
in Shiraz. The most effect and recorded family effective on sinusitis was Apiaceae family. The most organ used was 
fruit used by 34% and the highest form of usage was decoction with 80 percent. Full information of Ethnobotanical 
remedies to treat sinusitis in the city of Shiraz is followed in Table 1 and graphs 1, 2 and 3. 
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Table 1. Scientific name of the plant, family, Persian name, used parts, the traditional method used and therapeutic effect on traditional 
indigenous knowledge in the treatment of sinusitis 
 
Scientific name Family Persian names Usable Part of plant How to use Traditional Therapeutic  
effect in Shiraz 
Amygdalus scoparia Spach Rosaceae Badam Kouhi Fruit Decoction Sinusitis 
Echinophora platyloba DC. Apiaceae Khosharizeh Aerial Decoction Sinusitis 
Haplophyllum perforatum L Rutaceae Mord Seed & Leaf Decoction Sinusitis 
Descurainia Sophia (L.) Schr. Cruciferae Khakeshir Fruit Decoction Sinusitis 
Prangos acaulis (DC.) Bornm Apiaceae Jashir Kotole Fruit Decoction Sinusitis 
Borago officinalis Boraginaceae Gole ghav zaban Flower Decoction Sinusitis 
Matricaria recutita Asteraceae Babooneh Flower Decoction Sinusitis 
Lavandula stoechas L Labiatae Ostokhodous Aerial Decoction Sinusitis 
 


















Sinusitis is the fifth most common disease in America. Sinusitis is an inflammation, or swelling of the tissue lining 
the sinuses. Normally, sinuses such as frontal ethmoid, maxillary and sphenoid are filled with air, but when sinuses 
become blocked and filled with fluid, germs (bacteria, viruses, and fungi) can grow and cause an infection. The 
medicinal plants including Amygdalus scoparia Spach, Echinophora platyloba DC., Haplophyllum perforatum L, 
Lavandula stoechas L, Borago officinalis, Matricaria recutita, Descurainia Sophia (L.) Schr and Haplophyllum 
perforatum L are used to treat sinusitis in Shiraz.  Many of these plants contain phenolic compounds including 
flavonoids, flavonoids, polyphenols, anthocyanins, tannins and many other pharmaceutical bioactive ingredients that 
have effects on sinusitis [56-70]. The phenolic components of medicinal plants have antimicrobial activities [90-93]. 
The presented plants in this article have also phenolic compounds. Therefore, these plants should impose their 
antimicrobial activities, at least in part, through phenolic compounds. Phenolic compounds in plants have also 
antioxidant activities [94-103]. Therefore, in sinusitis which is associated increase in free radicals they should be 
beneficial. It should be noted that there are a lot of other diseases which are aggravated with free radicals [104-111]. 
Hence, the associated diseases with sinusitis may also get benefit with these plants antioxidants. Inflammation is ilso 
predominant in sinusitis and the other property of flavonoids is anti-inflammatory effects. Therefore, they may be 
beneficial in this way, too. It should be noted that there are other plants with these compounds [112-127] which may 
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